{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:43:25Z","timestamp":1784771005496,"version":"3.55.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.intimp.2013.05.022","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T15:30:26Z","timestamp":1371915026000},"page":"260-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function"],"prefix":"10.1016","volume":"17","author":[{"given":"Sunil K.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.05.022_bb0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.21.120601.141057","article-title":"The regulatory role of Valpha14 NKT cells in innate and acquired immune response","volume":"21","author":"Taniguchi","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0010","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.intimp.2013.05.022_bb0015","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/ni.2096","article-title":"Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria","volume":"12","author":"Kinjo","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1084\/jem.20102229","article-title":"Invariant NKT cells are required for airway inflammation induced by environmental antigens","volume":"208","author":"Wingender","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.17.1.297","article-title":"The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids","volume":"17","author":"Porcelli","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0030","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.immunol.23.021704.115742","article-title":"Toward an understanding of NKT cell biology: progress and paradoxes","volume":"23","author":"Kronenberg","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0040","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.20051625","article-title":"Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity","volume":"202","author":"Zajonc","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0045","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ni.2401","article-title":"The yin and yang of CD1d recognition","volume":"13","author":"Adams","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0050","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/emboj.2012.54","article-title":"Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor","volume":"31","author":"Lopez-Sagaseta","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.intimp.2013.05.022_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2011.03.006","article-title":"The immutable recognition of CD1d","volume":"34","author":"Adams","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2013.05.022_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.immuni.2011.02.001","article-title":"A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells","volume":"34","author":"Wun","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2013.05.022_bb0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/ni.2051","article-title":"A semi-invariant Valpha10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties","volume":"12","author":"Uldrich","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.2372","article-title":"Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor","volume":"13","author":"Patel","year":"2012","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.intimp.2013.05.022_bb0075","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/eji.201142350","article-title":"Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte","volume":"42","author":"Rhost","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-3083.2012.02750.x","article-title":"Immunomodulatory type II natural killer T lymphocytes in health and disease","volume":"76","author":"Rhost","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0085","doi-asserted-by":"crossref","first-page":"19007","DOI":"10.1073\/pnas.1109066108","article-title":"Vbeta2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen","volume":"108","author":"Patel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.05.022_bb0090","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20051381","article-title":"A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance","volume":"202","author":"Terabe","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0095","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1172\/JCI31602","article-title":"Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease","volume":"117","author":"Halder","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2013.05.022_bb0100","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/intimm\/7.7.1157","article-title":"Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations","volume":"7","author":"Makino","year":"1995","journal-title":"Int Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.7538697","article-title":"CD1 recognition by mouse NK1+ T lymphocytes","volume":"268","author":"Bendelac","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.intimp.2013.05.022_bb0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jmcb\/mjr035","article-title":"NKT cell self-reactivity: evolutionary master key of immune homeostasis?","volume":"4","author":"Issazadeh-Navikas","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0115","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ni.2143","article-title":"Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals","volume":"12","author":"Brennan","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0120","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.20102555","article-title":"Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection","volume":"208","author":"Brigl","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0125","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1073\/pnas.0604812103","article-title":"Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice","volume":"103","author":"Fujii","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.05.022_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-065X.2007.00561.x","article-title":"Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity","volume":"220","author":"Fujii","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.intimp.2013.05.022_bb0135","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.4049\/jimmunol.178.5.2853","article-title":"Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice","volume":"178","author":"Shimizu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0140","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1073\/pnas.0801375105","article-title":"NK T cells provide lipid antigen-specific cognate help for B cells","volume":"105","author":"Leadbetter","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.05.022_bb0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1126\/science.283.5399.225","article-title":"CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells","volume":"283","author":"Schofield","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.intimp.2013.05.022_bb0150","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.4049\/jimmunol.175.5.3309","article-title":"Alpha-galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor","volume":"175","author":"Ko","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2567.2006.02413.x","article-title":"The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner","volume":"119","author":"Lang","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2013.05.022_bb0160","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/IAI.00002-10","article-title":"CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies","volume":"78","author":"Devera","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2013.05.022_bb0165","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.4049\/jimmunol.174.9.5681","article-title":"Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d","volume":"174","author":"Belperron","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0170","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4049\/jimmunol.174.4.1787","article-title":"Cutting edge: antibody production to pneumococcal polysaccharides requires CD1 molecules and CD8+ T cells","volume":"174","author":"Kobrynski","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0175","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1073\/pnas.0700191104","article-title":"Invariant NKT cells sustain specific B cell responses and memory","volume":"104","author":"Galli","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.05.022_bb0180","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1084\/jem.20091314","article-title":"Invariant NKT cells limit activation of autoreactive CD1d-positive B cells","volume":"207","author":"Wermeling","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2012.02.008","article-title":"Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells","volume":"36","author":"Bosma","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2013.05.022_bb0190","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1182\/blood-2007-10-117309","article-title":"Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production","volume":"111","author":"Lang","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.intimp.2013.05.022_bb0195","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1189\/jlb.1111559","article-title":"Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation","volume":"91","author":"Joshi","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fmicb.2012.00429","article-title":"Molecular recognition of paired receptors in the immune system","volume":"3","author":"Kuroki","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ni954","article-title":"Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors","volume":"4","author":"Iizuka","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1440-1711.1998.00726.x","article-title":"Natural killer cell proliferation induced by anti-NK1.1 and IL-2","volume":"76","author":"Reichlin","year":"1998","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0220","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0952-7915(02)00337-0","article-title":"Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?","volume":"14","author":"Vivier","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0225","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1007\/s00018-011-0797-0","article-title":"Regulation of immune cell function and differentiation by the NKG2D receptor","volume":"68","author":"Zafirova","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.intimp.2013.05.022_bb0230","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1073\/pnas.0502439102","article-title":"The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure","volume":"102","author":"Garrity","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.05.022_bb0235","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nri2144","article-title":"Promiscuity and the single receptor: NKG2D","volume":"7","author":"Eagle","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0240","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.biocel.2009.07.005","article-title":"NKG2D and its ligands","volume":"41","author":"Obeidy","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0245","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.4049\/jimmunol.1201314","article-title":"Mouse tumor vasculature expresses NKG2D ligands and can be targeted by chimeric NKG2D-modified T cells","volume":"190","author":"Zhang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0250","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1158\/0008-5472.CAN-10-3200","article-title":"Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T cells and tumor cells","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2013.05.022_bb0255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-065X.2010.00962.x","article-title":"Transcriptional control of invariant NKT cell development","volume":"238","author":"Das","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.intimp.2013.05.022_bb0260","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ni.1841","article-title":"Raising the NKT cell family","volume":"11","author":"Godfrey","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0265","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2007.08.020","article-title":"Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development","volume":"27","author":"Griewank","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2013.05.022_bb0270","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ni710","article-title":"NKT cells derive from double-positive thymocytes that are positively selected by CD1d","volume":"2","author":"Gapin","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0275","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.278.5343.1623","article-title":"Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors","volume":"278","author":"Cui","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.intimp.2013.05.022_bb0280","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1126\/science.1103440","article-title":"Lysosomal glycosphingolipid recognition by NKT cells","volume":"306","author":"Zhou","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.intimp.2013.05.022_bb0285","doi-asserted-by":"crossref","first-page":"e19890","DOI":"10.1371\/journal.pone.0019890","article-title":"The Ras\/MAPK pathway is required for generation of iNKT cells","volume":"6","author":"Hu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2013.05.022_bb0290","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ni.1865","article-title":"The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage","volume":"11","author":"Hu","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0295","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.coi.2007.02.009","article-title":"On the road: progress in finding the unique pathway of invariant NKT cell differentiation","volume":"19","author":"Kronenberg","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0300","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.immuni.2008.07.011","article-title":"The transcription factor PLZF directs the effector program of the NKT cell lineage","volume":"29","author":"Savage","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2013.05.022_bb0305","doi-asserted-by":"crossref","first-page":"e24441","DOI":"10.1371\/journal.pone.0024441","article-title":"Altered development of NKT cells, gammadelta T cells, CD8 T cells and NK cells in a PLZF deficient patient","volume":"6","author":"Eidson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2013.05.022_bb0310","doi-asserted-by":"crossref","first-page":"e28648","DOI":"10.1371\/journal.pone.0028648","article-title":"Distinct and overlapping effector functions of expanded human CD4+, CD8alpha+ and CD4-CD8alpha-invariant natural killer T cells","volume":"6","author":"O'Reilly","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2013.05.022_bb0315","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.1069017","article-title":"A thymic precursor to the NK T cell lineage","volume":"296","author":"Benlagha","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.intimp.2013.05.022_bb0320","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.4049\/jimmunol.169.5.2397","article-title":"NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation","volume":"169","author":"Gadue","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0325","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.4049\/jimmunol.176.7.4059","article-title":"Long-term retention of mature NK1.1+ NKT cells in the thymus","volume":"176","author":"Berzins","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0335","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaut.2009.07.010","article-title":"Application of tissue-specific NK and NKT cell activity for tumor immunotherapy","volume":"33","author":"Subleski","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.intimp.2013.05.022_bb0340","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood-2005-04-1579","article-title":"Regulation of ITAM-positive receptors: role of IL-12 and IL-18","volume":"107","author":"Ortaldo","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.05.022_bb0345","doi-asserted-by":"crossref","first-page":"11287","DOI":"10.1073\/pnas.0801631105","article-title":"Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population","volume":"105","author":"Coquet","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.05.022_bb0350","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.4049\/jimmunol.0901059","article-title":"Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions","volume":"183","author":"Doisne","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0355","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20061551","article-title":"Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia","volume":"204","author":"Michel","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0360","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.180.8.5167","article-title":"Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion","volume":"180","author":"Rachitskaya","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0365","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1084\/jem.20080698","article-title":"A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity","volume":"205","author":"Terashima","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0370","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/eji.200940278","article-title":"NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d","volume":"41","author":"Kuylenstierna","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0375","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imlet.2008.07.001","article-title":"Tumor-derived soluble MICs impair CD3(+)CD56(+) NKT-like cell cytotoxicity in cancer patients","volume":"120","author":"Wang","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.intimp.2013.05.022_bb0380","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1258\/ebm.2012.011272","article-title":"High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus","volume":"237","author":"Guo","year":"2012","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.intimp.2013.05.022_bb0385","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10067-009-1322-9","article-title":"Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus","volume":"29","author":"Li","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0390","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0897.2008.00603.x","article-title":"The role of invariant NKT cells in pre-eclampsia","volume":"60","author":"Miko","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0395","doi-asserted-by":"crossref","first-page":"e1000588","DOI":"10.1371\/journal.ppat.1000588","article-title":"Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy","volume":"5","author":"Joshi","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.intimp.2013.05.022_bb0400","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(02)00305-9","article-title":"Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection","volume":"16","author":"Baron","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2013.05.022_bb0405","doi-asserted-by":"crossref","first-page":"18187","DOI":"10.1073\/pnas.0708968104","article-title":"Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus","volume":"104","author":"Vilarinho","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.05.022_bb0410","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20050956","article-title":"Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells","volume":"202","author":"Liu","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0415","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ni827","article-title":"Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs","volume":"3","author":"Fujii","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0420","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/157339509787314369","article-title":"Beyond stressed self: evidence for NKG2D ligand expression on healthy cells","volume":"5","author":"Eagle","year":"2009","journal-title":"Curr Immunol Rev"},{"key":"10.1016\/j.intimp.2013.05.022_bb0425","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1586\/erv.09.56","article-title":"How do natural killer T cells help B cells?","volume":"8","author":"Lang","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.intimp.2013.05.022_bb0430","doi-asserted-by":"crossref","first-page":"e1002838","DOI":"10.1371\/journal.ppat.1002838","article-title":"Invariant NKT Cells: regulation and function during viral infection","volume":"8","author":"Juno","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.intimp.2013.05.022_bb0435","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nri2904","article-title":"Presumed guilty: natural killer T cell defects and human disease","volume":"11","author":"Berzins","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0440","first-page":"293","article-title":"CD1-restricted T cells and tumor immunity","volume":"314","author":"Swann","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0445","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what's in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0450","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20051600","article-title":"Functionally distinct NKT cell subsets and subtypes","volume":"202","author":"Seino","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0455","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.20011786","article-title":"Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining","volume":"195","author":"Gumperz","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0460","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.4049\/jimmunol.178.5.2827","article-title":"IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production","volume":"178","author":"Coquet","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0465","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cellimm.2008.10.002","article-title":"Murine NKT cells produce Th17 cytokine interleukin-22","volume":"254","author":"Goto","year":"2009","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0470","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20011908","article-title":"Distinct functional lineages of human V(alpha)24 natural killer T cells","volume":"195","author":"Lee","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0475","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.4049\/jimmunol.171.10.5140","article-title":"NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells","volume":"171","author":"Hermans","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.05.022_bb0480","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20050953","article-title":"Differential antitumor immunity mediated by NKT cell subsets in vivo","volume":"202","author":"Crowe","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0485","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.20020092","article-title":"A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas","volume":"196","author":"Crowe","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0490","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1084\/jem.20021616","article-title":"CD1d-restricted help to B cells by human invariant natural killer T lymphocytes","volume":"197","author":"Galli","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.05.022_bb0495","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/eji.200738000","article-title":"Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers","volume":"38","author":"Devera","year":"2008","journal-title":"Eur J Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913002208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913002208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T22:54:07Z","timestamp":1539557647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913002208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1567576913002208"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.05.022","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}